MedsManager Pre-Release Users

• An Apple iPhone, running a recent version of iOS
• Familiarity with the iOS Calendar, Reminders, and iOS Widgets
• An email application that will allow you to receive email (like the TestFlight invitation from Apple). MedsManager itself does not use email.
• The TestFlight application, which can be downloaded for free from the Apple App Store. We'll walk through that later.
• Familiarity with the iOS Files app, including sufficient knowledge to open and save files.
• Available space on the phone to allow small files (logs) to be saved

Apple will deliver pre-release versions of the app to you via an Apple app called TestFlight. If selected, you will receive an invitation from Apple that will admit you to the program.

You report them via a simple form on this page.

ABSOLUTELY NOT. You can export your lists for your convenience, but the App does not sync to the Cloud or otherwise move your data off of your device without your direct involvement. That's as true for production users as it is for pre-release users. 

Technically? Not at all. MedsManager doesn't care if you use it to track your consumption of bread, eggs and milk. It's all the same to the software.

Personally, I'd prefer to engage testers who have "some skin in the game". You don't have to name actual meds--item names are limited to only five characters specifically to prevent users fully naming their meds--the important thing is that YOU understand what an item name represents. So, I'd prefer you track something meaningful to you.

Yes! I'd encourage it! Use the app to create meaningful lists -- take advantage of the premium features, too. When you reach a point where you're happy with each list, export it to your phone's files. Once the software enters production, you can import them back into the software. Easy peasy!

NOPE. While a feature like that might be very convenient for users, doing so would require significant investment in secure server storage and communications to safeguard Protected Health Information and Personally Identifiable Information. At this time, we believe such a feature to be cost-prohibitive.